Natera, Inc.
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Other Genetic Tests Revenue [legacy through Q3 2019] by Quarter
Other Genetic Tests Revenue ($M) [legacy through Q3 2019] ($M)
Natera Other Genetic Tests Revenue [legacy through Q3 2019]: $3.23M in Q3 2019, up 4.2% from a year earlier. No newer figure appears in the documents we track.
Where the Q3 2019 figure comes from
Source: Form 10-Q (2019-11-08) ↗
Reported in Form 10-K/10-Q Note — Disaggregated Product Revenue (2016–2019Q3).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Genetic Tests Revenue ($M) [legacy through Q3 2019] ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2019 | Sep 30, 2019 | 3.23 | +4.2% | Form 10-Q (2019-11-08) ↗ |
| Q2 2019 | Jun 30, 2019 | 4.35 | +35.1% | Form 10-Q (2019-08-09) ↗ |
| Q1 2019 | Mar 31, 2019 | 3.37 | +23.0% | Form 10-Q (2019-05-10) ↗ |
| Q4 2018 | Dec 31, 2018 | 3.21 | +11.8% | Form 10-K (2019-03-15) ↗ |
| Q3 2018 | Sep 30, 2018 | 3.10 | +14.0% | Form 10-Q (2019-11-08) ↗ |
| Q2 2018 | Jun 30, 2018 | 3.22 | +9.9% | Form 10-Q (2019-08-09) ↗ |
| Q1 2018 | Mar 31, 2018 | 2.74 | – | Form 10-Q (2019-05-10) ↗ |
| Q4 2017 | Dec 31, 2017 | 2.87 | – | Form 10-K (2019-03-15) ↗ |
| Q3 2017 | Sep 30, 2017 | 2.72 | – | Form 10-Q (2018-11-09) ↗ |
| Q2 2017 | Jun 30, 2017 | 2.93 | – | Form 10-Q (2018-08-09) ↗ |
Cite this data
StockData. (2026). Natera Other Genetic Tests Revenue [legacy through Q3 2019] ($M), quarterly Q2 2017–Q3 2019 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/rev-legacy-other-genetic
See every metric in the Natera KPI table. Data updated Nov 2, 2026.